Details of the Drug

General Information of Drug (ID: DMECV92)

Drug Name
FCX-013
Indication
Disease Entry ICD 11 Status REF
Scleroderma 4A42 Phase 1 [1]
Cross-matching ID
TTD ID
D02IIM

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)